Jiangsu Ailot Pharmaceutical Research Institute is located in Jiangning High-tech Zone, Nanjing, established in August 2018, with registered capital of 14 million yuan. the first batch of 2019 through the record of new R&D institutions in Nanjing, the overall R&D operation area of more than 5,000 square meters, with GMP-compliant laboratories and cell preparation centers, the number of R&D operation personnel is more than 50, with PhDs and master's degree accounted for more than 70% The number of R&D and operation personnel is more than 50, with doctoral and master's degrees accounting for more than 70%. We have international leading advantages in core technology development, and have developed into a high-level new R&D institution with an overseas collaborative innovation center (Boston) and more than 30 incubated and introduced enterprises.
The core scientists graduated or worked in the United States, Switzerland, Sweden and other famous universities, relying on the resources of research cooperation in Germany, the United States and Switzerland to develop innovative biomedical technologies and products adapted to the expansion of China and the world.
It has built a postgraduate workstation approved by the Education Department of Jiangsu Province, and has become a postgraduate training base for biology and medicine in China Pharmaceutical University, and has been awarded the honors of Top Talent of Nanjing, Innovative Entrepreneur of Nanjing, and so on. Selected as a high-tech enterprise, one of the first 30 leading biopharmaceutical enterprises in Nanjing, 38 high-level R&D organizations and 15 platform R&D organizations. Won the 2022 National Disruptive Technology Innovation Competition Grand Final Winner Award.
